Chlorine in PDB 5tf5: Crystal Structure of Human Kat-2 in Complex with A Reversible Inhibitor
Enzymatic activity of Crystal Structure of Human Kat-2 in Complex with A Reversible Inhibitor
All present enzymatic activity of Crystal Structure of Human Kat-2 in Complex with A Reversible Inhibitor:
2.6.1.39;
2.6.1.7;
Protein crystallography data
The structure of Crystal Structure of Human Kat-2 in Complex with A Reversible Inhibitor, PDB code: 5tf5
was solved by
A.Nematollahi,
G.Sun,
W.B.Church,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
46.13 /
1.81
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
88.883,
99.275,
107.923,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
21.9 /
24.5
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of Human Kat-2 in Complex with A Reversible Inhibitor
(pdb code 5tf5). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the
Crystal Structure of Human Kat-2 in Complex with A Reversible Inhibitor, PDB code: 5tf5:
Jump to Chlorine binding site number:
1;
2;
Chlorine binding site 1 out
of 2 in 5tf5
Go back to
Chlorine Binding Sites List in 5tf5
Chlorine binding site 1 out
of 2 in the Crystal Structure of Human Kat-2 in Complex with A Reversible Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Crystal Structure of Human Kat-2 in Complex with A Reversible Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl501
b:0.3
occ:1.00
|
CL1
|
B:7AR501
|
0.0
|
0.3
|
1.0
|
C18
|
B:7AR501
|
1.8
|
96.8
|
1.0
|
HE3
|
A:MET22
|
2.6
|
95.9
|
1.0
|
O
|
A:HOH783
|
2.7
|
55.3
|
1.0
|
C20
|
B:7AR501
|
2.7
|
82.4
|
1.0
|
C17
|
B:7AR501
|
2.8
|
97.8
|
1.0
|
CL2
|
B:7AR501
|
3.1
|
0.8
|
1.0
|
H
|
A:ARG20
|
3.2
|
0.9
|
1.0
|
CE
|
A:MET22
|
3.3
|
79.9
|
1.0
|
HD21
|
B:LEU382
|
3.3
|
53.7
|
1.0
|
HE1
|
A:MET22
|
3.5
|
95.9
|
1.0
|
HE2
|
A:MET22
|
3.5
|
95.9
|
1.0
|
HD22
|
B:LEU382
|
3.5
|
53.7
|
1.0
|
H
|
A:ILE19
|
3.7
|
0.7
|
1.0
|
HB2
|
A:ARG20
|
3.9
|
0.0
|
1.0
|
CD2
|
B:LEU382
|
3.9
|
44.7
|
1.0
|
N
|
A:ARG20
|
4.0
|
0.1
|
1.0
|
C21
|
B:7AR501
|
4.0
|
63.5
|
1.0
|
HD11
|
B:LEU382
|
4.1
|
49.4
|
1.0
|
C16
|
B:7AR501
|
4.1
|
82.7
|
1.0
|
HD13
|
B:LEU382
|
4.2
|
49.4
|
1.0
|
N
|
A:ILE19
|
4.3
|
0.6
|
1.0
|
HA
|
A:ILE19
|
4.3
|
0.9
|
1.0
|
HA
|
A:PRO18
|
4.4
|
0.0
|
1.0
|
HD2
|
A:ARG20
|
4.4
|
0.1
|
1.0
|
HG3
|
A:ARG20
|
4.4
|
0.5
|
1.0
|
CD1
|
B:LEU382
|
4.5
|
41.2
|
1.0
|
HD23
|
B:LEU382
|
4.6
|
53.7
|
1.0
|
C15
|
B:7AR501
|
4.6
|
69.1
|
1.0
|
HG2
|
A:MET22
|
4.6
|
0.9
|
1.0
|
HB3
|
A:MET22
|
4.6
|
0.3
|
1.0
|
HG
|
B:SER143
|
4.6
|
50.7
|
1.0
|
CB
|
A:ARG20
|
4.6
|
0.7
|
1.0
|
HH22
|
B:ARG399
|
4.6
|
33.4
|
1.0
|
H
|
A:THR21
|
4.7
|
0.9
|
1.0
|
CA
|
A:ILE19
|
4.7
|
0.6
|
1.0
|
CA
|
A:ARG20
|
4.8
|
0.7
|
1.0
|
SD
|
A:MET22
|
4.9
|
93.7
|
1.0
|
CG
|
A:ARG20
|
4.9
|
0.6
|
1.0
|
CG
|
B:LEU382
|
4.9
|
41.0
|
1.0
|
HB2
|
A:PRO18
|
4.9
|
0.0
|
1.0
|
C
|
A:ILE19
|
4.9
|
0.4
|
1.0
|
CD
|
A:ARG20
|
5.0
|
0.8
|
1.0
|
|
Chlorine binding site 2 out
of 2 in 5tf5
Go back to
Chlorine Binding Sites List in 5tf5
Chlorine binding site 2 out
of 2 in the Crystal Structure of Human Kat-2 in Complex with A Reversible Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Crystal Structure of Human Kat-2 in Complex with A Reversible Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl501
b:0.8
occ:1.00
|
CL2
|
B:7AR501
|
0.0
|
0.8
|
1.0
|
C20
|
B:7AR501
|
1.8
|
82.4
|
1.0
|
HD21
|
B:LEU382
|
2.7
|
53.7
|
1.0
|
C18
|
B:7AR501
|
2.7
|
96.8
|
1.0
|
C21
|
B:7AR501
|
2.8
|
63.5
|
1.0
|
HG
|
B:SER143
|
2.8
|
50.7
|
1.0
|
HZ
|
B:PHE387
|
2.9
|
34.1
|
1.0
|
HE2
|
B:PHE387
|
3.0
|
33.0
|
1.0
|
CL1
|
B:7AR501
|
3.1
|
0.3
|
1.0
|
CZ
|
B:PHE387
|
3.2
|
28.4
|
1.0
|
CE2
|
B:PHE387
|
3.2
|
27.5
|
1.0
|
OG
|
B:SER143
|
3.3
|
42.2
|
1.0
|
CD2
|
B:LEU382
|
3.4
|
44.7
|
1.0
|
HD23
|
B:LEU382
|
3.4
|
53.7
|
1.0
|
HD22
|
B:LEU382
|
3.6
|
53.7
|
1.0
|
O
|
A:HOH783
|
3.8
|
55.3
|
1.0
|
HB3
|
B:SER143
|
3.8
|
39.8
|
1.0
|
HH12
|
B:ARG399
|
3.8
|
30.4
|
1.0
|
HB3
|
B:ALA386
|
4.0
|
41.0
|
1.0
|
C17
|
B:7AR501
|
4.0
|
97.8
|
1.0
|
C15
|
B:7AR501
|
4.1
|
69.1
|
1.0
|
NH1
|
B:ARG399
|
4.1
|
25.3
|
1.0
|
CB
|
B:SER143
|
4.1
|
33.1
|
1.0
|
CE1
|
B:PHE387
|
4.1
|
27.4
|
1.0
|
CD2
|
B:PHE387
|
4.2
|
26.6
|
1.0
|
HB1
|
B:ALA386
|
4.2
|
41.0
|
1.0
|
HH11
|
B:ARG399
|
4.3
|
30.4
|
1.0
|
H
|
B:SER143
|
4.5
|
24.1
|
1.0
|
HE1
|
B:PHE387
|
4.5
|
32.9
|
1.0
|
CB
|
B:ALA386
|
4.6
|
34.2
|
1.0
|
C16
|
B:7AR501
|
4.6
|
82.7
|
1.0
|
HB2
|
B:SER143
|
4.6
|
39.8
|
1.0
|
HD2
|
B:PHE387
|
4.6
|
31.9
|
1.0
|
HH22
|
B:ARG399
|
4.7
|
33.4
|
1.0
|
CZ
|
B:ARG399
|
4.7
|
27.4
|
1.0
|
CG
|
B:LEU382
|
4.7
|
41.0
|
1.0
|
HD11
|
B:LEU382
|
4.7
|
49.4
|
1.0
|
HB3
|
A:PRO18
|
4.8
|
0.0
|
1.0
|
HG
|
B:LEU382
|
4.8
|
49.2
|
1.0
|
NH2
|
B:ARG399
|
4.9
|
27.8
|
1.0
|
CD1
|
B:PHE387
|
4.9
|
23.1
|
1.0
|
CG
|
B:PHE387
|
5.0
|
25.9
|
1.0
|
HD21
|
B:ASN202
|
5.0
|
21.9
|
1.0
|
|
Reference:
A.Nematollahi,
G.Sun,
G.Jayawickrama,
J.R.Hanrahan,
W.B.Church.
Crystal Structure and Mechanistic Analysis of A Novel Human Kynurenine Aminotransferase-2 Reversible Inhibitor Med.Chem.Res. 2017.
ISSN: ISSN 1054-2523
DOI: 10.1007/S00044-017-1950-6
Page generated: Fri Jul 26 17:26:41 2024
|